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Abstract
Purpose: To report the clinical and genetic study of a child with bilateral anophthalmia.
Methods: A 14-year-old Egyptian boy, born from consanguineous parents, underwent a general and a full
ophthalmological examination. Mutation screen of the A/M genes with recessive inheritance was done stepwise and
DNA was analyzed by Sanger sequencing.
Results: Bilateral anophthalmia, arachnodactyly of the feet and high arched palate were observed on general
examination. The parents were first cousins and healthy. Sequencing analysis revealed a novel compound
heterozygous mutation in one of the copy of exon 2 of VSX2 and a possible deletion of at least exon 2 on the other
allele.
Conclusions: A compound heterozygous VSX2 mutation associated with anophthalmia was identified in a
patient from an Egyptian consanguineous family. This report brings the number of VSX2 mutation in anophthalmia/
microphthalmia (A/M) to 13. Functional consequences of the reported changes still need to be characterized, as well
as the percentage of A/M caused by mutations in the VSX2 gene. This family also shows that despite consanguinity,
heterozygous mutations can also happen and one should not restrict the molecular analysis to homozygous
mutations.
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Introduction
Anophthalmia (A) is a rare and severe ocular malformation
characterized by the absence of one or both eye at birth with absent
vision [1]. Unilateral anophthalmia is often associated with
microphthalmia (M), which is characterized by a small eye. Together,
anophthalmia/microphthalmia (A/M) have a prevalence of 1 per
10,000 cases per birth, microphthalmia being more frequent [1]. In
more than 50% of affected patients, limbs, musculoskeletal, or
craniofacial anomalies have been reported [2]. Non-syndromic A/M is
often associated with other ocular anomalies such as colobomas, cysts,
cataracts, microcornea or sclerocornea. To date, the underlying genetic
cause is identifiable in approximately 25 to 30% of A/M patients as
chromosomal aberrations or monogenic mutations and in up to 80%
of severe anophthalmia with colobomas as monogenic mutations [2,3].
Several genes of A/M are related with autosomal-dominant
inheritance and include GDF6, BMP4 OTX2, and SOX2 [4].
Autosomal-recessive inheritance has also been reported and involves
VSX2 [5]. Other genes, PAX6, RAX, [6] VAX1, FOXE3, STRA6,
SMOC1, [7] SIX3, HESX1, BCOR, SHH, CHD7, IKBKG, NDP,
POMT1, HMX1, and SIX6 and have been related to A/M, both
syndromic, and non-syndromic [3]. Mutations in SOX2, OTX2 and
ALDH1A3 are the most common known genetic cause of A/M and
account for respectively 4-20%, 3-8% and 10% of cases [2,8]. The
remaining genes are thus very rare and the rate of A/M mutations is
made difficult to assess.
Visual system homeobox 2 (VSX2), originally called CHX10, is a
gene located on chromosome 14, which contains 5 exons. This gene
encodes a homeobox protein described as retinal-specific in human,
[9] mice [10] and zebrafish embryos [11-13]. In mice, early Vsx2
expression has been described in brainstem, thalamus and spinal cord
[10]. In human [11], mice [14] and zebrafish, [12] VSX2/Vsx2 loss of
function causes microphthalmia and variable associated ocular
anomalies.
So far, twelve VSX2 mutations have been identified in 21 probands
from 14 consanguineous families descending from Arabic countries or
neighbouring regions [11,15-20]. Different ocular phenotypes have
been described in these 14 families ranging from severe anophthalmia
to microphthalmia with or without additional ocular features such as
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colobomas, cataracts, or optic nerve hypoplasia for example.
Extraocular features have been described in one report so far as
developmental delay with behavioural problems, autism,
cryptorchidism, ovarian defects, limb anomaly and hearing
impairment [18].
In this study, a novel compound heterozygous VSX2 mutation has
been identified in a patient of Egyptian origin affected with bilateral
anophthalmia. We further expand the clinical and genetic description
of A/M caused by VSX2 that has very few alleles identified to date
related to A/M.
Methods
The ethic board of the University of Alexandria, Egypt, approved
this study and informed consent was obtained from the parents of the
family. The study was performed in adherence to the tenets of the
declaration of Helsinki (1983 Revision).
Clinical examination
A 14-year-old boy from an Egyptian consanguineous family
underwent full medical examination. Pregnancy history of the mother,
antenatal and postnatal development history of the child and family
history were taken. A family pedigree was drawn (Figure 1). Growth,
skull, face, chest, heart, abdomen, uro-genital, skeletal system, nervous
system and skin were included in the general medical examination. A
complete ophthalmic examination with an echography of both orbits
was performed. History of parents’ health was taken and eye
examination performed.
Genetic analysis
The genetic analysis was performed in the 14-year-old boy and his
parents. Genomic DNA was extracted from peripheral blood using the
standard procedures. Mutation screen of the A/M genes with recessive
inheritance was done stepwise, starting with ALDH1A3, RAX, and
VSX2. The five exons and exon-intron junctions of VSX2 were
screened by direct sequencing after PCR amplification.
Figure 1: Pedigree of the consanguineous Egyptian family. Squares
indicate males, circles females. Filled symbol: affected 14-year-old
boy with bilateral anophthalmia. Double lines indicate
consanguinity.
PCR products were amplified using 20 ng of genomic DNA in a 20
μl reaction mixture (10 μl master-mix, 5 μl H2O, 1.5 μl of forward
primer and 1.5 μl reverse primer). The primers were designed by using
Primer3 software (http://primer3.wi.mit.edu/) (Table 1). The various
amplicons were directly sequenced as previously described [6].
Exon Primer sequence (5’-3’) : forward/reverse
VSX2-1 GTGATTGGCTGCTCAGCTCT/ GGCCTGGCAGGAACTTTT
VSX2-2 CTTCCTGGGGAGACAGAGC/ CGAAAATAGGGTCCGAGAGA
VSX2-3 CCAGGAGACACAGAGGAAGG/ CAAGCACATGCCCACAGT
VSX2-4 ACAGAGGGCACCATGGAGTA/ CTCTCCTGCTAGGCTGCTGT
VSX2-5 AAGGCTTTCTGCTCGTCCTT/ TGTCTCAGCATGGTCCAGAG
Table 1: Primers used for PCR amplification and direct sequencing of VSX2 coding exons and intronic junctions.
Results
Bilateral anophthalmia was diagnosed in the 14 year old boy,
associated with narrow palpebral fissure and large upper eyebrows
(Figures 2A and 2B). Orbital echography confirmed the diagnosis and
excluded orbital cysts remnants. The complete medical examination
revealed a high arched palate and arachnodactyly of the toes (Figure
2C). No other malformations were present. The patient was born at
term after an uneventful pregnancy. Neuropsychological, motor
development and growth parameters were normal. The parents were
both healthy, had no ocular anomalies and family history was free.
The pedigree of the family suggested an autosomal recessive
inheritance (Figure 1). Sequencing analysis of all VSX2 exons revealed
a potential homozygous mutation in exon 2 of the patient, [c.422delA],
that resulted in a theoretical frameshift and the generation of
termination codon 19 amino acids downstream (p.N141Ifs*20) (Figure
3A). In fact, based on the analysis of the parents, this mutation was
hemizygous in the affected boy.
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Figure 2: Pictures of the affected child. A: The 14-year-old boy affected with bilateral anophthalmia. B: Note the absence of eye when the
upper palpebral lid is reversed. C: Feet with arachnodactyly.
Indeed, the unaffected father was carrying the [c.422delA] variant
in exon 2 (Figure 3C) while his mother was normal (Figure 3B),
suggesting the presence of a deletion that included at least exon 2. No
mutations were detected in the patient’s siblings. The VSX2 c.422delA
mutation was not detected in 96 controls from North Africa nor in 96
Swiss controls. Mutation screen of all other A/M genes did not reveal
any other anomaly or mutation.
Figure 3: Partial electropherogram of VSX2 exon 2. Partial Sanger
sequencing of VSX2 exon 2. A: the patient shows a hemizygous
deletion of nucleotide A at position 422. B: The mother has a wild-
type sequence. As the mother does not show a heterozygous
sequence, she must have a deletion of at least exon 2 of VSX2. C:
The father is heterozygous for the deletion.
Discussion
VSX2 is a homeobox gene and a member of the paired-like CVC
gene family which are consisted of a pair homeodomain and an
additional conserved region, called the CVC domain [13]. VSX2 is one
of the earliest specific markers of the neuroretinal lineage and is
expressed in neuroretinal pluripotent cells and late-born bipolar cells
[21]. It is strongly conserved in vertebrates and zebrafish [1,2]. Passini
et al. [13] worked on zebrafish eye development to analyse the possible
role of Vsx2. It is variously expressed at different embryonic stages
with an enhanced and restrictive function that, finally, leads to a
normal developed eye. Recently, Phillips et al. [21] revealed the
multiple roles of VSX2 that included proliferation, cell fate and
differentiation. Therefore, it is not surprising that mutations in VSX2
lead to malformations due to embryonic perturbation of the ocular
program [22]. Systemic malformations are not explained by ocular
expression analyses.
Only twelve mutations in VSX2 have been identified in autosomal
recessive A/M, so far (Table 2). When screening large series, VSX2
mutations seem to account for a small proportion of A/M reaching a
maximum of 2% [11]. Six of the reported mutations are thought to
cause loss of function and three other interestingly affect the VSX2
CVC domain with a « hotspot » at Arg200 [11,17,18]. From a clinical
point of view, all the described patients with identified VSX2
mutations had A/M associated with colobomas. Several cases had in
addition cataracts or other ocular anomalies (Table 2). Of the latter,
only one patient, of Afghan origin, was described with globe remnants
on MRI and a homozygous nonsense p.Arg200* mutation (Table 2)
[10]. This girl had several non-ocular anomalies, including
microcephaly, moderate learning difficulties, and underdeveloped
optic nerves and chiasm [10]. All but one report of VSX2 mutations
were associated with only ocular phenotypes, the exception was made
by Iseri et al. [18] (Table 2) who described extraocular features in
different A/M patients, including the Afghan girl described above. No
definite causative relationship between the non-ocular features and the
VSX2 mutation has been demonstrated.
In the present study, we identified new compound heterozygous
VSX2 mutations causing severe bilateral anophthalmia. To our
knowledge, this deletion in the VSX2 gene [c.422delA; p.N141Ifs*19]
localized in exon 2 has never been described before. Both mutations
may generate loss of function, either by nonsense-mediated decay or
by shorter VSX2 proteins.
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N° Locatio
n
DNA
mutation
Protein mutation Mutation
Type
Genotype Affected
individual
s
Ocular
Phenotype
Non ocular
phenotype
Ethnic
origin
Inheritanc
e
Reference
1 Exon 1 c.249delG p.Leu84SerfsX57 Deletion
and
frameshift
Homozygou
s
7 (from 2
families)
Bilateral
microphthalmia
and coloboma
(Bilateral
microphthalmia
and
“disorganized
eye” Reis et al)
Oestrogen
and insulin
deficiency, leg
length
discrepancy
Iran Recessive [5,18],
2 Intron 1 c.371-1G>A Aberrant splicing Splice
site
Homozygou
s
2 A/M and iris
coloboma
None Jewish-
Syrian
Recessive [16]
3 Exon 2 c.422delA
c.371-?
_455+?del
p.N141Ifs*19,
Deletion exon 2
Deletion
and
frameshift
Compound
heterozygou
s
1 Bilateral
anophthalmia
None Egypt Recessive Present report
4 Intron 2 c.456-2A>G Aberrant splicing Splice
site
Homozygou
s
1 Severe
bilateral
microphthalmia
, iris
colobomas,
retinal
detachments,
hypoplastic
optic nerves
None Turkey Recessive [19]
5 Exon 3 Exon
deletion
~4kb del around
exon 3
Exon
deletion
Homozygou
s
16 A/M None Arab
(Bedouin)
Recessive [16]
6 Exon 4 c.598C>T p.Arg200X Homozygou
s
1 Bilateral
anophthalmia,
hypoplastic
optic nerves
and chiasm
Moderate
communicatio
n and learning
difficulties,
small head
circumference
.
Afghanista
n
Recessive [18]
7 Exon 4 c.599G>A p.Arg200Gln Missense Homozygou
s
2 Bilateral
microphthalmia
, iris coloboma,
dislocated
lens, and
cataract
None Turkey Recessive [11]
8 Exon 4 c.599G>C p.Arg200Pro Missense Homozygou
s
1 Bilateral
microphthalmia
, anterior
segment
dysgenesis,
lens
dislocation ,
retinal
detachment
None United
Arab
Emirates
Recessive [11]
9 Exon 4 c.599G>C p.Arg200Pro Missense Homozygou
s
6 (from 2
families)
Bilateral
severe
microphthalmia
and cloudy
corneas
None Qatar Recessive [11]
10 Exon 4 c.
71_72insG,
c.667G>A
p.Ala25Argfs*101
, p.Gly223Arg
(Compound
heterozygous)
Frameshif
t
Compound
heterozygou
s
1 Severe
bilateral
colobomatous
microphthalmia
, and cataract
None Unspecifie
d
[20]
11 Exon 4 c.679C>T p.Arg227Trp Missense Homozygou
s
2 Isolated A/M None Arab
(Bedouin)
Recessive [16]
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11 Exon 4 c.679C>T p.Arg227Trp Missense Homozygou
s
1 Extreme
bilateral
microphthalmia
Hearing
impairment,
severe
learning
difficulties,
autism
Pakistan Recessive [18]
12 Exon 4 c.668G>C p.G223A Missense Homozygou
s
7 Bilateral
microphthalmia
None Pakistan Recessive [5]
Table 2: VSX2 mutations causing recessive anophthalmia/micropthalmia.
The 14-year-old boy we studied did not harbour any globe
remnants on orbital echography, no such case has been described to
date so that it represents the most severe ocular phenotype described
in association with a VSX2 mutation. Narrow palpebral fissure and
large upper eyebrows (Figures 2A, B) have been seen in several
Egyptian A/M patients before and may likely be related to the lack of
globes [6]. In addition we observed clinically an arachnodactyly of the
toes (Figure 2C) that is very pronounced in this patient. Such a
phenotype has not been reported before and the only other report of a
limb anomaly refers to an Iranian patient with the p.Leu84SerfsX57
mutation, who also showed a left leg length discrepancy of 2 cm and
tapering fingers. She later developed mild insulin and iron deficiency,
and ovarian problems as well [18]. It is of interest to note that the case
we describe as well as the Iranian girl could represent limb anomalies
often associated with A/M, despite the fact that the causative effect of
the VSX2 mutation cannot be unequivocally assessed. The present
report suggests that VSX2 mutations may not only affect the ocular
area as thought to date, considering the predominant expression of
VSX2 in the neuroretinal lineage, but also other organs [11]. Finally,
because different VSX2 mutations can generate similar phenotypes
(Table 2), and different phenotypes can be caused by identical
mutations, it is difficult to establish genotype-phenotype correlations.
More studies and reports are needed, especially of cases with VSX2
residual function.
All VSX2 mutations reported so far, including the present one, are
in families of Middle-East origins or neighbouring countries, namely
Pakistan and Afghanistan (Table 2). Thus it has been suggested that
VSX2 mutations were more frequent or specific to Middle-East and
South Asian background origins [5,16-18]. Nevertheless, when
screening this gene in exclusively consanguineous A/M kindred from
unspecific ethnic origin, the rate of VSX2 mutations is higher, and
varies from 15% to 33% [5,18]. VSX2 mutations may be more frequent
than expected and are to date related only to recessive A/M as
confirmed by the present report. High rate of consanguinity may
explain the higher frequency of VSX2 mutations in Middle-Eastern
than in European patients, rather than a shared ancestry. Of note is
that despite consanguinity, compound heterozygosity may be present
as reported here and by Chassaing et al. [20] and one should not
restrict the molecular analysis to homozygous mutations only for
VSX2.
In conclusion, the present study identified a compound
heterozygous mutations including two deletions in VSX2, a single
nucleotide and a whole exon that have never been described before, in
a patient with severe bilateral anophthalmia. This study expands the
number of described VSX2 mutations causing A/M to 12 and
describes the most severe case of A/M reported to date, in association
with the first report of associated arachnodactyly. Definite causality of
VSX2 for the non-ocular phenotype cannot yet be assessed but
clinicians should be aware of this eventuality. The present study shows
that despite consanguinity, compound heterozygosity may be present
and one should not restrict the molecular analysis to homozygous
mutations only.
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